DFITX | TGREX | DFITX / TGREX | |
Total Expense Ratio | 0.27 | 0.90 | 30% |
Annual Report Gross Expense Ratio | 0.27 | 1.42 | 19% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 22.154 | 8.142 | 272% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.35B | 41.5M | 8,060% |
Annual Yield % from dividends | 5.08 | 1.94 | 263% |
Returns for 1 year | 2.57 | -4.49 | -57% |
Returns for 3 years | 37.65 | 30.69 | 123% |
Returns for 5 years | 23.42 | 27.10 | 86% |
Returns for 10 years | 25.71 | 66.34 | 39% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 35.53 | 0.94 | +2.72% |
Fidelity Advisor Biotechnology Z | |||
FCDIX | 40.68 | 0.54 | +1.35% |
Fidelity Advisor Stock Selector Sm Cp I | |||
IMCVX | 9.85 | 0.11 | +1.13% |
Voya Multi-Manager Mid Cap Value I | |||
BBMIX | 11.68 | 0.09 | +0.78% |
BBH Select Series - Mid Cap I | |||
LYRWX | 14.53 | 0.10 | +0.69% |
Lyrical International Value Equity Instl |